Двойное открытое параллельное исследование влияния квинаприла по сравнению с лизиноприлом на дисфункцию эндотелия у курящих пациентов, страдающих мягкой и умеренной артериальной гипертензией в сочетании со стенокардией и имеющих микроальбуминурию и дислип
Двойное открытое параллельное исследование влияния квинаприла по сравнению с лизиноприлом на дисфункцию эндотелия у курящих пациентов, страдающих мягкой и умеренной артериальной гипертензией в сочетании со стенокардией и имеющих микроальбуминурию и дислип
Арутюнов Г.П., Кобалава Ж.Д., Карпов Ю.А., Чернявская Т.К., Овчинников Р.С., Былова Н.А., Дзидзария М.И., Волгина О.Н., Митрофанов П.В., Шавгулидзе К.Б., Лискина Е.Б., Бейтуганов А.А., Иванов К.И., Баланина Н.О., Воеводина Н.Ю., Степанова Л.В., Марфун А.А. Двойное открытое параллельное исследование влияния квинаприла по сравнению с лизиноприлом на дисфункцию эндотелия у курящих пациентов, страдающих мягкой и умеренной артериальной гипертензией в сочетании со стенокардией и имеющих микроальбуминурию и дислип. Consilium Medicum. 2008; 10 (11): 41–48.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Список литературы
1. Онищенко Г.Г. Информационное письмо главного санитарного врача. 04.05.2000. www.nonsmoking.ru
2. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J. 2001; 22 (7): 554–72.
3 Александров А.А., Шальнова С.А., Деев А.Д. Распространение курения среди врачей РФ. Информационная статья. www.nonsmoking.ru
4. Pittilo RM, Cigarette smoking, endothelial injury and atherosclerosis. J. Smoking Related Dis., 1993; 4: 17–25.
5. Hamasaki H, Sato J, Masuda H et al. Effect of nicotine on the intimal hyperplasia after endothelial removal of the rabbit carotid artery. Gen Pharmacol 1997; 28 (5): 653–9.
6. Davis JW, Shelton L, Eigenberg DA et al. Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther 1985; 37 (5): 529–33.
7. Vita JA, Treasure CB, Yeung AC et al. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation. 1992; 85 (4): 1390–7.
8. Nabel EG, Ganz P, Gordon JB et al., Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation. 1988; 77 (1): 43–52.
9. Butler R, Morris AD, Struthers AD. Lisinopril improves endothelial function in chronic cigarette smokers. Clin Sci (Lond). 2001; 101 (1): 53–8.
10. Higgins JP. Can angiotensin-converting enzyme inhibitors reverse atherosclerosis? South Med J. 2003; 96 (6): 569–79.
11. Chalon S, Moreno H Jr, Hoffman BB et al. Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers. Clin Pharmacol Ther. 1999; 65 (3): 295–303.
12. Pellegrini MP, Newby DE, Johnston NR et al. Vitamin C has no effect on endothelium-dependent vasomotion and acute endogenous fibrinolysis in healthy smokers. J Cardiovasc Pharmacol. 2004; 44 (1): 117–124.
13. Schindler TH, Magosaki N, Jeserich M et al. Effect of ascorbic acid on endothelial dysfunction of epicardial coronary arteries in chronic smokers assessed by cold pressor testing. Cardiology. 2000; 94 (4): 239–46.
14. Drossos GE, Toumpoulis IK, Katritsis DG et al. Is vitamin C superior to diltiazem for radial artery vasodilation in patients awaiting coronary artery bypass grafting? J Thorac Cardiovasc Surg. 2003; 125 (2): 330–5.
15. Zanchetti A, Hansson L, Clement D et al. Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers? J Hypertens. 2003; 21 (4): 797–804.
16. Schlaifer JD, Wargovich TJ, O'Neill B et al. Effects of quinapril on coronary blood flow in coronary artery disease patients with endoth elial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction. Am J Cardiol. 1997; 80 (12): 1594–7.
17. Yamasaki K, Aoki M, Makino H et al. Effect of nifedipine on endothelial function in normotensive smokers: potential contribution of increase in circulating hepatocyte growth factor. J Hum Hypertens. 2004; 18 (10): 701–5.
18. Oida K, Ebata K, Kanehara H et al. Effect of cilostazol on impaired vasodilatory response of the brachial artery to ischemia in smokers. J Atheroscler Thromb. 2003; 10 (2): 93–8.
19. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002; 360 (9326): 7–22.
20. Milionis HJ, Rizos E, Mikhailidis DP. Smoking diminishes the beneficial effect of statins: observations from the landmark trials. Angiology. 2001; 52 (9): 575–87.
2. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J. 2001; 22 (7): 554–72.
3 Александров А.А., Шальнова С.А., Деев А.Д. Распространение курения среди врачей РФ. Информационная статья. www.nonsmoking.ru
4. Pittilo RM, Cigarette smoking, endothelial injury and atherosclerosis. J. Smoking Related Dis., 1993; 4: 17–25.
5. Hamasaki H, Sato J, Masuda H et al. Effect of nicotine on the intimal hyperplasia after endothelial removal of the rabbit carotid artery. Gen Pharmacol 1997; 28 (5): 653–9.
6. Davis JW, Shelton L, Eigenberg DA et al. Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther 1985; 37 (5): 529–33.
7. Vita JA, Treasure CB, Yeung AC et al. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation. 1992; 85 (4): 1390–7.
8. Nabel EG, Ganz P, Gordon JB et al., Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation. 1988; 77 (1): 43–52.
9. Butler R, Morris AD, Struthers AD. Lisinopril improves endothelial function in chronic cigarette smokers. Clin Sci (Lond). 2001; 101 (1): 53–8.
10. Higgins JP. Can angiotensin-converting enzyme inhibitors reverse atherosclerosis? South Med J. 2003; 96 (6): 569–79.
11. Chalon S, Moreno H Jr, Hoffman BB et al. Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers. Clin Pharmacol Ther. 1999; 65 (3): 295–303.
12. Pellegrini MP, Newby DE, Johnston NR et al. Vitamin C has no effect on endothelium-dependent vasomotion and acute endogenous fibrinolysis in healthy smokers. J Cardiovasc Pharmacol. 2004; 44 (1): 117–124.
13. Schindler TH, Magosaki N, Jeserich M et al. Effect of ascorbic acid on endothelial dysfunction of epicardial coronary arteries in chronic smokers assessed by cold pressor testing. Cardiology. 2000; 94 (4): 239–46.
14. Drossos GE, Toumpoulis IK, Katritsis DG et al. Is vitamin C superior to diltiazem for radial artery vasodilation in patients awaiting coronary artery bypass grafting? J Thorac Cardiovasc Surg. 2003; 125 (2): 330–5.
15. Zanchetti A, Hansson L, Clement D et al. Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers? J Hypertens. 2003; 21 (4): 797–804.
16. Schlaifer JD, Wargovich TJ, O'Neill B et al. Effects of quinapril on coronary blood flow in coronary artery disease patients with endoth elial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction. Am J Cardiol. 1997; 80 (12): 1594–7.
17. Yamasaki K, Aoki M, Makino H et al. Effect of nifedipine on endothelial function in normotensive smokers: potential contribution of increase in circulating hepatocyte growth factor. J Hum Hypertens. 2004; 18 (10): 701–5.
18. Oida K, Ebata K, Kanehara H et al. Effect of cilostazol on impaired vasodilatory response of the brachial artery to ischemia in smokers. J Atheroscler Thromb. 2003; 10 (2): 93–8.
19. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002; 360 (9326): 7–22.
20. Milionis HJ, Rizos E, Mikhailidis DP. Smoking diminishes the beneficial effect of statins: observations from the landmark trials. Angiology. 2001; 52 (9): 575–87.
Авторы
Г.П.Арутюнов, Ж.Д.Кобалава, Ю.А.Карпов, Т.К.Чернявская,
Р.С.Овчинников, Н.А.Былова, М.И.Дзидзария, О.Н.Волгина,
П.В.Митрофанов, К.Б.Шавгулидзе, Е.Б.Лискина,
А.А.Бейтуганов, К.И.Иванов, Н.О.Баланина,
Н.Ю.Воеводина, Л.В.Степанова, А.А.Марфун
Р.С.Овчинников, Н.А.Былова, М.И.Дзидзария, О.Н.Волгина,
П.В.Митрофанов, К.Б.Шавгулидзе, Е.Б.Лискина,
А.А.Бейтуганов, К.И.Иванов, Н.О.Баланина,
Н.Ю.Воеводина, Л.В.Степанова, А.А.Марфун
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.